福瑞股份收盘下跌1.30%，滚动市盈率85.65倍，总市值84.97亿元

Company Overview - Furuya Co., Ltd. closed at 31.9 yuan, down 1.30%, with a rolling PE ratio of 85.65 times and a total market value of 8.497 billion yuan [1] - The company ranks 104th in the medical device industry, which has an average PE ratio of 51.29 times and a median of 37.02 times [1] Institutional Holdings - As of the first quarter of 2025, 18 institutions hold shares in Furuya Co., Ltd., including 14 funds, 3 others, and 1 insurance company, with a total holding of 49.9011 million shares valued at 1.593 billion yuan [1] Business Focus - Furuya Co., Ltd. specializes in the production and sales of drugs in the liver disease field, development and sales of diagnostic equipment, and related medical services, with its main product being the compound tortoise shell soft liver tablets [1] Financial Performance - In the first quarter of 2025, the company reported revenue of 330 million yuan, a year-on-year increase of 2.35%, and a net profit of 28.6367 million yuan, a year-on-year decrease of 32.97%, with a gross profit margin of 76.76% [1]